With a share price of $1,182, Eli Lilly (LLY) is positioned for about 76% potential growth over the next three years in a ...

Eli Lilly's next leg of growth may have less to do with how well its weight loss drugs work and more to do with how many ...

Eli Lilly has whipsawed shareholders in 2026, but one under-the-radar catalyst in its pipeline could change the trajectory ...

SpaceX recently completed a record IPO.

There are good reasons to invest in Lilly and to hold off.

If you are wondering whether Eli Lilly stock is still worth considering at its current level, the key question is how its price lines up with the underlying value of the business. The share price most ...

At first glance, Eli Lilly's (NYSE: LLY) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assume anything this expensive must be priced ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Eli Lilly (NYSE: LLY) stock, maker of the Mounjaro and Zepbound GLP-1 weight loss drugs, enjoyed a modest bounce on Monday, rising 3.6% through 10:30 a.m. ET on some good news for Lilly... and some ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...